Skip to main content

Animations

MJFF Publications

2041 - 2050 of 6082 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Predicting survival in patients with glioblastoma using MRI radiomic features extracted from radiation planning volumes
    Journal Name: Journal of Neuro-Oncology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11060-021-03939-9
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12514
    Citation Count: 16
  • Summary Details
    OPEN
    Title: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/trc2.12274
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A Spatiotemporal Map of the Aging Mouse Brain Reveals White Matter Tracts as Vulnerable Foci
    Journal Name: SSRN Electronic Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2139/ssrn.4260648
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Association between cigarette smoking and Parkinson’s disease: a neuroimaging study
    Journal Name: Therapeutic Advances in Neurological Disorders
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/17562864221092566
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12255
    Citation Count: 39
  • Summary Details
    OPEN
    Title: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related Research
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.14283/jpad.2022.7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study
    Journal Name: Aging Brain
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.